Tysnes OB, Storstein A. Epidemiology of Parkinson's disease. J Neural Transm (Vienna). 2017;124(8):901–5.
Article
Google Scholar
Ascherio A, Schwarzschild MA. The epidemiology of Parkinson's disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257–72.
Article
PubMed
Google Scholar
Collaborators GBDPsD. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018;17(11):939–53.
Article
Google Scholar
Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord. 2001;16(3):448–58.
Article
CAS
PubMed
Google Scholar
Aquino CC, Fox SH. Clinical spectrum of levodopa-induced complications. Mov Disord. 2015;30(1):80–9.
Article
CAS
PubMed
Google Scholar
Stacy M, Bowron A, Guttman M, Hauser R, Hughes K, Larsen JP, LeWitt P, Oertel W, Quinn N, Sethi K, Stocchi F. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment. Mov Disord. 2005;20(6):726–33.
Article
PubMed
Google Scholar
Stocchi F, Antonini A, Barone P, Tinazzi M, Zappia M, Onofrj M, Ruggieri S, Morgante L, Bonuccelli U, Lopiano L, Pramstaller P, Albanese A, Attar M, Posocco V, Colombo D, Abbruzzese G. Early DEtection of wEaring off in Parkinson disease: the DEEP study. Parkinsonism Relat Disord. 2014;20(2):204–11.
Article
CAS
PubMed
Google Scholar
Warren Olanow C, Kieburtz K, Rascol O, Poewe W, Schapira AH, Emre M, Nissinen H, Leinonen M, Stocchi F. Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinson’s disease. Mov Disord. 2013;28(8):1064–71.
Article
CAS
PubMed
Google Scholar
Altavista MC, Cassetta E, Brusa L, Viselli F, Denaro A, Ventriglia M, Pasqualetti P, Peppe A. Wearing-off detection in clinical practice: the wearing off real practice key (WORK-PD) study in Parkinson's disease. Parkinsonism Relat Disord. 2015;21(2):95–100.
Article
CAS
PubMed
Google Scholar
Matthews H, Stamford J, Saha R, Martin A. Exploring issues around wearing-off and quality of life: the OFF-PARK survey of people with Parkinson’s disease and their care partners. J Park Dis. 2015;5(3):533–9.
Google Scholar
Murata M, Hasegawa K, Kanazawa I, Fukasaka J, Kochi K, Shimazu R. Zonisamide improves wearing-off in Parkinson's disease: a randomized, double-blind study. Mov Disord. 2015;30(10):1343–50.
Article
CAS
PubMed
Google Scholar
Chou KL, Stacy M, Simuni T, Miyasaki J, Oertel WH, Sethi K, Fernandez HH, Stocchi F. The spectrum of “off” in Parkinson's disease: what have we learned over 40 years? Parkinsonism Relat Disord. 2018;51:9–16.
Article
PubMed
Google Scholar
Kelly MJ, Lawton MA, Baig F, Ruffmann C, Barber TR, Lo C, Klein JC, Ben-Shlomo Y, Hu MT. Predictors of motor complications in early Parkinson's disease: a prospective cohort study. Mov Disord. 2019;34(8):1174–83.
Article
PubMed
PubMed Central
Google Scholar
Rizos A, Martinez-Martin P, Odin P, Antonini A, Kessel B, Kozul TK, Todorova A, Douiri A, Martin A, Stocchi F, Dietrichs E, Chaudhuri KR. Europar, the in-MPDSG. Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: an international multicenter study. Parkinsonism Relat Disord. 2014;20(11):1231–5.
Article
CAS
PubMed
Google Scholar
Onozawa R, Tsugawa J, Tsuboi Y, Fukae J, Mishima T, Fujioka S. The impact of early morning off in Parkinson's disease on patient quality of life and caregiver burden. J Neurol Sci. 2016;364:1–5.
Article
PubMed
Google Scholar
Stocchi F, Coletti C, Bonassi S, Radicati FG, Vacca L. Early-morning OFF and levodopa dose failures in patients with Parkinson's disease attending a routine clinical appointment using time-to-ON questionnaire. Eur J Neurol. 2019;26(5):821–6.
Article
CAS
PubMed
Google Scholar
Stocchi F, Rabey JM. Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease. Eur J Neurol. 2011;18(12):1373–8.
Article
CAS
PubMed
Google Scholar
Schapira AH, Barone P, Hauser RA, Mizuno Y, Rascol O, Busse M, Salin L, Juhel N, Poewe W. Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial. Neurology. 2011;77(8):767–74.
Article
CAS
PubMed
Google Scholar
Trenkwalder C, Kies B, Rudzinska M, Fine J, Nikl J, Honczarenko K, Dioszeghy P, Hill D, Anderson T, Myllyla V, Kassubek J, Steiger M, Zucconi M, Tolosa E, Poewe W, Surmann E, Whitesides J, Boroojerdi B, Chaudhuri KR, Recover SG. Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord. 2011;26(1):90–9.
Article
PubMed
Google Scholar
Isaacson S, Lew M, Ondo W, Hubble J, Clinch T, Pagan F. Apomorphine subcutaneous injection for the Management of Morning Akinesia in Parkinson's disease. Mov Disord Clin Pract. 2017;4(1):78–83.
Article
PubMed
Google Scholar
Hauser RA, Isaacson SH, Ellenbogen A, Safirstein BE, Truong DD, Komjathy SF, Kegler-Ebo DM, Zhao P, Oh C. Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease. Parkinsonism Relat Disord, 2019;64:175-80.
Stacy M, Hauser R, Oertel W, Schapira A, Sethi K, Stocchi F, Tolosa E. End-of-dose wearing off in Parkinson disease: a 9-question survey assessment. Clin Neuropharmacol. 2006;29(6):312–21.
Article
PubMed
Google Scholar
Chapuis S, Ouchchane L, Metz O, Gerbaud L, Durif F. Impact of the motor complications of Parkinson's disease on the quality of life. Mov Disord. 2005;20(2):224–30.
Article
PubMed
Google Scholar
Reichmann H, Klasser M, Apfel R, Fendji D. Efficacy and tolerability of rasagiline in daily clinical use—a post marketing observational study in patients with Parkinson’s disease focusing on non-motor symptoms and QoL. Basal Ganglia. 2015;5(4):101–6.
Article
Google Scholar
Stocchi F, Fossati C, Torti M. Rasagiline for the treatment of Parkinson's disease: an update. Expert Opin Pharmacother. 2015;16(14):2231–41.
Article
PubMed
CAS
Google Scholar
Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.
Article
PubMed
PubMed Central
Google Scholar
Bhidayasiri R, Hattori N, Jeon B, Chen RS, Lee MK, Bajwa JA, Mok VC, Zhang B, Syamsudin T, Tan LC, Jamora RD, Pisarnpong A, Poewe W. Asian perspectives on the recognition and management of levodopa ‘wearing-off’ in Parkinson’s disease. Expert Rev Neurother. 2015;15(11):1285–97.
Article
CAS
PubMed
Google Scholar
Espay AJ, Morgante F, Merola A, Fasano A, Marsili L, Fox SH, Bezard E, Picconi B, Calabresi P, Lang AE. Levodopa-induced dyskinesia in Parkinson disease: current and evolving concepts. Ann Neurol. 2018;84(6):797–811.
Article
PubMed
Google Scholar
Fox SH, Katzenschlager R, Lim SY, Barton B, de Bie RMA, Seppi K, Coelho M, Sampaio C. International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson's disease. Mov Disord. 2018;33(8):1248–66.
Article
CAS
PubMed
Google Scholar
Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, Weintraub D, Sampaio C. Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review. Mov Disord. 2019;34(2):180–98.
Article
PubMed
PubMed Central
Google Scholar
Kim YE, Jeon BS, Yang HJ, Ehm G, Yun JY, Kim HJ, Kim JM. REM sleep behavior disorder: association with motor complications and impulse control disorders in Parkinson's disease. Parkinsonism Relat Disord. 2014;20(10):1081–4.
Article
PubMed
Google Scholar
Melamed E. Early-morning dystonia. A late side effect of long-term levodopa therapy in Parkinson's disease. Arch Neurol. 1979;36(5):308–10.
Article
CAS
PubMed
Google Scholar
Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H, Hallett M, Miyasaki J, Stevens J, Weiner WJ. Practice parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the quality standards Subcommittee of the American Academy of neurology. Neurology. 2006;66(7):983–95.
Article
CAS
PubMed
Google Scholar
Hogl B, Rothdach A, Wetter TC, Trenkwalder C. The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease. Neuropsychopharmacology. 2003;28(10):1866–70.
Article
PubMed
CAS
Google Scholar